clinical practice guidelines and remission Archives

Abstract Number: 2373 • ACR/ARHP Annual Meeting 2013
UK Clinical Practice Use Of Biologics In Monotherapy For The Treatment Of Patients With Rheumatoid Arthritis
Andrew J. Ostor¹, G. Chelliah², Theodoros Dimitroulas³, Margaret-Mary Gordon⁴, Nicola Hewson⁵, JA Mitchell⁵, Senam Beckley-Kartey⁶, Hok Pang⁶ and Jose Saraiva-Ribeiro⁶, ¹Department of Rheumatology, Addenbrookes Hospital, Cambridge, United Kingdom, ²Clinical Trials Unit, Wrightington Hospital, Wigan, United Kingdom, ³Department of Rheumatology, Research and Development, Dudley Group NHS Foundation Trust, Russell’s Hall Hospital, Dudley, United Kingdom, ⁴Rheumatology Department, Gartnavel General Hospital, Glasgow, United Kingdom, ⁵Syne Qua Non Ltd., Diss, United Kingdom, ⁶Medical Department, Roche, Welwyn Garden City, United Kingdom
Background/Purpose: NICE guidelines recommend that patients with severe active rheumatoid arthritis (RA) be treated with a biologic disease‑modifying anti‑rheumatic drug as monotherapy (bDMARD mono) if…

Abstracts tagged "clinical practice guidelines and remission"